DOI: 10.1128/AAC.01502-17
Article Information
PubMed
Published By
History
- Received July 22, 2017
- Returned for modification August 9, 2017
- Accepted August 21, 2017
- Published online October 24, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology.
All Rights Reserved
.
Article Versions
- Accepted Manuscript version (September 05, 2017).
- You are viewing the most recent version of this article.
Author Information
- aJohns Hopkins University School of Medicine, Baltimore, Maryland, USA
- bSeoul National University College of Medicine and Boramae Medical Center, Seoul, Republic of Korea
- Address correspondence to Eric L. Nuermberger, enuermb{at}jhmi.edu.
Citation Park S-W, Tasneen R, Converse PJ, Nuermberger EL. 2017. Immunodeficiency and intermittent dosing promote acquired rifamycin monoresistance in murine tuberculosis. Antimicrob Agents Chemother 61:e01502-17. https://doi.org/10.1128/AAC.01502-17 .
